Total Payments
$137,530
2024 Payments
$28,273
Companies
17
Transactions
87
Payment Breakdown by Category
Consulting$99,549 (72.4%)
Travel$24,760 (18.0%)
Other$11,795 (8.6%)
Food & Beverage$1,405 (1.0%)
Education$22.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $99,549 | 31 | 72.4% |
| Travel and Lodging | $24,760 | 22 | 18.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,795 | 3 | 8.6% |
| Food and Beverage | $1,405 | 30 | 1.0% |
| Education | $22.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $40,658 | 36 | $0 (2019) |
| American Regent | $30,119 | 5 | $0 (2023) |
| Marinus Pharmaceuticals, Inc. | $10,150 | 1 | $0 (2024) |
| Kyowa Kirin, Inc. | $9,285 | 5 | $0 (2023) |
| PFIZER INC. | $8,500 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $7,700 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,175 | 6 | $0 (2024) |
| Ascendis Pharma, Inc. | $5,330 | 2 | $0 (2022) |
| BioMarin Pharmaceutical Inc. | $5,103 | 15 | $0 (2019) |
| Merck Sharp & Dohme LLC | $4,800 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,273 | 10 | Marinus Pharmaceuticals, Inc. ($10,150) |
| 2023 | $25,704 | 10 | American Regent ($11,760) |
| 2022 | $10,730 | 5 | Ascendis Pharma, Inc. ($5,330) |
| 2021 | $7,570 | 4 | PFIZER INC. ($5,000) |
| 2020 | $4,116 | 1 | American Regent ($4,116) |
| 2019 | $35,575 | 31 | Shire North American Group Inc ($16,229) |
| 2018 | $5,828 | 8 | Shire North American Group Inc ($4,828) |
| 2017 | $19,735 | 18 | Shire North American Group Inc ($19,600) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 10/23/2024 | Day One Biopharmaceuticals | OJEMDA (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Mirum Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 10/01/2024 | CSL Behring | HEMGENIX (Biological) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Hematology | ||||||
| 04/12/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 03/25/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 03/14/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 03/07/2024 | Marinus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,150.00 | General |
| 01/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NATPARA (PARATHYROID HORMONE) (Drug) | Consulting Fee | Cash or cash equivalent | $1,522.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/22/2023 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,670.00 | General |
| 06/22/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $42.56 | General |
| 06/22/2023 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $32.69 | General |
| 06/16/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Education | In-kind items and services | $22.00 | General |
| Category: Hyperthyroidism | ||||||
| 05/08/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $64.37 | General |
| 05/01/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $93.80 | General |
| Category: Surgical Site Infection | ||||||
| 05/01/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $60.85 | General |
| Category: Surgical Site Infection | ||||||
| 03/09/2023 | American Regent | INJECTAFER (Drug) | Consulting Fee | Cash or cash equivalent | $11,760.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/13/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 01/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NATPARA (PARATHYROID HORMONE) (Drug) | Consulting Fee | Cash or cash equivalent | $1,957.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2022 | Ascendis Pharma, Inc. | SKYTROFA (Drug) | Consulting Fee | Cash or cash equivalent | $2,665.00 | General |
| Category: Endocrinology | ||||||
| 09/15/2022 | Kyowa Kirin Co., Ltd | — | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| 08/19/2022 | Ascendis Pharma, Inc. | SKYTROFA (Drug) | Consulting Fee | Cash or cash equivalent | $2,665.00 | General |
| Category: Endocrinology | ||||||
| 06/08/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/28/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NATPARA (PARATHYROID HORMONE) (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
About Dr. Michael Levine, MD
Dr. Michael Levine, MD is a Pediatrics healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811033962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Levine, MD has received a total of $137,530 in payments from pharmaceutical and medical device companies, with $28,273 received in 2024. These payments were reported across 87 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($99,549).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location Philadelphia, PA
- Active Since 01/29/2007
- Last Updated 11/03/2014
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1811033962
Products in Payments
- INJECTAFER (Drug) $30,119
- NATPARA (Drug) $24,429
- NATPARA (PARATHYROID HORMONE) (Drug) $22,404
- SKYTROFA (Drug) $5,330
- HEMGENIX (Biological) $4,200
- OJEMDA (Drug) $3,500
- SurgX (Device) $154.65
- NP Thyroid 60 (Drug) $22.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Philadelphia
Matthew Gillespie, M.d, M.D
Pediatrics — Payments: $1.5M
Pediatrics $1.5M
Stephan Grupp, M.d, M.D
Pediatrics — Payments: $472,209
Pediatrics $472,209
Oscar Mayer, M.d, M.D
Pediatrics — Payments: $270,148
Pediatrics $270,148
Robert Shaddy, Md, MD
Pediatrics — Payments: $148,516
Pediatrics $148,516
Michael Grunstein, M.d, M.D
Pediatrics — Payments: $133,646
Pediatrics $133,646
Craig Alter, M.d, M.D
Pediatrics — Payments: $114,704
Pediatrics $114,704